Valuation : Grifols, S.A.

Market Cap 5.93B 6.89B 5.56B 5.09B 9.5B 651B 9.58B 65.81B 25.63B 333B 25.88B 25.31B 1,072B P/E 2026 *
12.6x
P/E 2027 * 9.64x
Enterprise Value 14.37B 16.71B 13.49B 12.34B 23.03B 1,579B 23.22B 160B 62.14B 807B 62.73B 61.37B 2,599B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.73x
Free-Float
79.65%
Yield 2026 *
2.78%
Yield 2027 * 3.04%
1 day-0.21%
1 week-1.26%
Current month+0.98%
1 month-1.31%
3 months+10.68%
6 months-0.44%
Current year-7.21%
1 week 9.75
Extreme 9.752
10.12
1 month 9.62
Extreme 9.622
10.32
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
12.87
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
22.64
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 58 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Chairman 76 2010-01-24
Director/Board Member 70 2000-04-12
Director/Board Member 62 2015-05-23
Date Insider Type Main position Quantity % Market Cap. Importance
2/26/26 Free

Director

7,679 0.0018%
2/26/26 Free

Director

1,408 0.0005%
2/18/26 Others

Director

1,408 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%-1.26%-16.71%-21.80% 6.87B
-1.33%+4.22%+49.31%+2.30% 85.08B
-3.72%+1.34%+501.58%+32.30% 60.21B
+0.95%+1.77%-15.77%-34.78% 59.71B
-1.60%-7.63%-3.65%+31.05% 51.1B
+0.09%-0.54%+9.26%+170.07% 48.73B
+0.75%+1.20%+58.28%-15.82% 32.9B
-0.36%+0.61%+47.80%+103.11% 26.11B
+0.79%-6.56%-2.56%+192.31% 22.6B
+1.10%-1.67%+64.17%+113.16% 16.42B
Average -0.36%-1.40%+69.17%+57.19% 40.97B
Weighted average by Cap. -0.75%-0.79%+92.17%+44.33%

Financials

2026 *2027 *
Net sales 7.66B 8.9B 7.18B 6.57B 12.27B 841B 12.37B 84.99B 33.1B 430B 33.41B 32.68B 1,384B 8.13B 9.45B 7.63B 6.98B 13.04B 894B 13.14B 90.3B 35.17B 457B 35.5B 34.73B 1,471B
Net income 536M 623M 503M 460M 858M 58.85B 865M 5.95B 2.32B 30.07B 2.34B 2.29B 96.85B 699M 813M 656M 600M 1.12B 76.83B 1.13B 7.76B 3.02B 39.26B 3.05B 2.99B 126B
Net Debt 8.45B 9.82B 7.93B 7.25B 13.53B 928B 13.64B 93.75B 36.51B 474B 36.86B 36.05B 1,527B 8.1B 9.42B 7.6B 6.96B 12.99B 890B 13.09B 89.96B 35.04B 455B 35.37B 34.6B 1,465B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,258
Date Price Change Volume
26-09-03 9.928 +0.30% 1,457,201
26-09-02 €9.898 -0.28% 1,163,545
26-09-01 €9.926 +0.96% 1,081,146
26-08-31 €9.832 -1.19% 962,512
26-08-28 €9.950 -1.04% 979,824
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.898EUR
Average target price
14.76EUR
Spread / Average Target
+49.10%

Quarterly revenue - Rate of surprise